Uniqure N.V. (QURE)

Last Year

27-Apr-23 -- 26-Apr-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Reduce

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

17

0

5

+1

0

+2

0

+3

Two Year Chart

27-Apr-22 -- 26-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
06-Feb-24 10:00 PM View:	23-Jun-23 Gift 0	Kaye Jack Director		Uniqure N.V. - QURE	(74%) 34.12K to 8.72K	0	0	--	--	Show Txns Hide Txns

20-Sep-23 4:45 PM View:	18-Sep-23 Sale ($43.57K)	Dolmetsch Ricardo President, R&D		Uniqure N.V. - QURE	(3%) 169.25K to 163.4K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 4:58 PM View:	01-Mar-24 Grant 0	Caloz Pierre Chief Operating Officer		Uniqure N.V. - QURE	8% 110.22K to 118.64K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 5:14 PM View:	01-Mar-24 Grant 0	Klemt Christian Chief Financial Officer		Uniqure N.V. - QURE	25% 132.85K to 166.45K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 5:19 PM View:	01-Mar-24 Grant 0	Kapusta Matthew C CEO, Managing Director Director		Uniqure N.V. - QURE	26% 468.74K to 590.84K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 5:10 PM View:	01-Mar-24 Grant 0	Abi-Saab Walid Chief Medical Officer		Uniqure N.V. - QURE	74% 67.2K to 116.7K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 4:54 PM View:	01-Mar-24 Grant 0	Potts Jeannette Chief Legal Officer		Uniqure N.V. - QURE	100% 0 to 96.6K	0	0	--	--	Show Txns Hide Txns